Dianthus Therapeutics (DNTH) Revenue (2022 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Revenue of $396000.0 for Q3 2025, down 81.77% year-over-year from $2.2 million in Q3 2024, and up 105.18% quarter-over-quarter from $193000.0 in Q2 2025.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Revenue (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $396000.0 for Q3 2025.
- In Q3 2025, Revenue fell 81.77% year-over-year to $396000.0; the TTM figure through Sep 2025 stood at $3.1 million (down 41.61% YoY), while the FY2024 annual figure was $6.2 million, up 120.63% from the prior year.
- Revenue for Q3 2025 stood at $396000.0, up from $193000.0 in the prior quarter.
- The five-year high for Revenue was $2.2 million in Q3 2024, with the low at $193000.0 in Q2 2025.
- The 4-year median for Revenue is $1.0 million (2023), against an average of $1.0 million.
- The sharpest annual moves came in 2024 and 2025: Revenue surged 211.27% in 2024, then slumped 89.64% in 2025.
- Dianthus Therapeutics' Revenue stood at $1.2 million in 2022, then tumbled by 63.74% to $426000.0 in 2023, then soared by 211.27% to $1.3 million in 2024, then plunged by 70.14% to $396000.0 in 2025.
- Business Quant data shows DNTH's Revenue at $396000.0 in Q3 2025, $193000.0 in Q2 2025, and $1.2 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Dianthus Therapeutics | 4.06 Bn | 3.66 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 874,000.00 |
| Dec 31, 2023 | 457,000.00 |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.17 Mn |